Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Acer Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference | ||
By: Nasdaq / GlobeNewswire - 31 Jan 2018 | Back to overview list |
|
NEWTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today announced that Chris Schelling, CEO and Founder, will provide a corporate overview at the LEERINK Partners 7th Annual Global Healthcare Conference, being held February 14-15, 2018 in New York. Acer Therapeutics Conference Presentation Details About Acer Therapeutics For more information, visit www.acertx.com. |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |